Astellas seeks FDA approval for tacrolimus tablets Pharmaceutical Business Review Astellas Pharma US has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) seeking approval for tacrolimus extended release capsules for the prophylaxis of organ rejection in adult kidney transplant recipients and adult ... |
